Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Incorporation of Controlled Release Agents in Lyophilized Products

Posted on By

SOP for Incorporation of Controlled Release Agents in Lyophilized Products

Standard Operating Procedure for Incorporation of Controlled Release Agents in Lyophilized Products

1) Purpose

This SOP outlines the procedure for incorporating controlled release agents into lyophilized products, ensuring prolonged release of the active ingredients over a specific duration while maintaining product stability.

2) Scope

This SOP applies to all personnel involved in the formulation, preparation, and testing of lyophilized products with controlled release agents, including formulation scientists, production operators, and QA personnel.

3) Responsibilities

  • Formulation Scientists: Responsible for selecting appropriate controlled release agents and designing the release profile for the formulation.
  • Operators: Responsible for incorporating the controlled release agents as per the Batch Manufacturing Record (BMR).
  • QA: Responsible for verifying the incorporation and release testing of the controlled release agents, ensuring documentation accuracy.
See also  Lyophilized Products : SOP for Preparation of Protein-Based Lyophilized Formulations

4) Procedure

4.1 Selection of Controlled Release Agents

4.1.1 Criteria for Selection

  • 4.1.1.1 The selected controlled release agents must be compatible with the active ingredients and should ensure a consistent release profile. Commonly used agents include polymers such as hydroxypropyl methylcellulose (HPMC) or poly(lactic-co-glycolic acid) (PLGA).

4.2 Incorporation of Controlled Release Agents

4.2.1 Weighing and Dispensing

  • 4.2.1.1 Weigh the controlled release agents using a calibrated balance as specified in the BMR.
  • 4.2.1.2 Add the controlled release agents to the formulation
solution and stir until fully dissolved or dispersed.

4.2.2 Mixing and Homogenization

  • 4.2.2.1 Stir the solution using a mechanical stirrer to ensure the controlled release agents are evenly distributed.
  • 4.2.2.2 Homogenize the mixture if necessary to ensure uniformity across the entire solution.

4.3 Filtration and Filling

  • 4.3.1 Filter the solution using a sterile 0.22-micron filter and fill into sterile vials as per the BMR for lyophilization.

4.4 Controlled Release Testing

  • 4.4.1 After lyophilization, perform release testing using in vitro dissolution methods to monitor the release profile of the active ingredients over time.
  • 4.4.2 Ensure that the release profile meets the specifications outlined in the BMR.

4.5 Documentation

Record all steps, including weighing, controlled release agent addition, filtration, and release testing, in the Controlled Release Agent Incorporation Logbook. All entries must be verified by QA personnel.

5) Abbreviations

  • BMR: Batch Manufacturing Record

6) Documents

  • Controlled Release Agent Incorporation Logbook

7) References

  • Pharmacopoeial guidelines for controlled release drug products and testing methods

8) SOP Version

Version 1.0

Annexure

Controlled Release Agent Incorporation Logbook Template

Date Formulation Name Batch No. Controlled Release Agent Release Profile Operator Initials QA Verification
DD/MM/YYYY Formulation Name Batch Number Agent Name Release Profile Result Operator Name QA Initials
             


See also  SOP for Selection and Preparation of Solvents for Lyophilized Formulations
Lyophilized Products Tags:Aseptic lyophilization process SOP, FDA guidelines for lyophilized products, Freeze-drying cycle development SOP, Lyophilized product SOP, Lyophilizer calibration SOP, Moisture content testing in lyophilized products, Pharmaceutical freeze-drying SOP, Quality control SOP for lyophilized drugs, SOP for cryoprotectants in lyophilized formulations, SOP for freeze-dried formulation optimization, SOP for handling lyophilized products, SOP for lyophilization of injectable drugs, SOP for lyophilization process in pharmaceuticals, SOP for lyophilization process validation, SOP for lyophilized antibiotics production, SOP for lyophilized product packaging, SOP for lyophilized product storage, SOP for lyophilized product vial filling, SOP for lyophilized vaccine production, SOP for lyophilizer equipment maintenance, SOP for pharmaceutical freeze-drying validation, SOP for primary drying in lyophilization, SOP for reconstitution of lyophilized drugs, SOP for secondary drying in lyophilization, SOP for stability testing of lyophilized products

Post navigation

Previous Post: SOP for Preparation of Multilamellar Vesicles (MLVs)
Next Post: SOP for Developing pH-Sensitive Nasal Sprays

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version